Platelet aggregation and histamine release were evaluated in normal an
d IgE pretreated human platelets exposed in vitro to IgE, anti-IgE and
thrombin. The response of platelets from atopic donors directly stimu
lated with anti-IgE was also evaluated. Histamine release was measured
by fluorimetric analysis of histamine content in platelets and in sup
ernatants. The morphology of platelets exposed to immunological and no
n-immunological stimuli was recorded using an electron microscope. A d
etectable amount of histamine was measured in quiescent platelets. The
ir exposure to varying concentrations of thrombin produces a progressi
ve aggregation which runs parallel to histamine release. The effects w
ere significantly enhanced in platelets pretreated with IgE. Incubatio
n of normal platelets with increasing concentrations of IgE myeloma pr
otein, or with anti-human IgE antibody was ineffective on both aggrega
tion and histamine release. However, incubation of platelets passively
sensitized with IgE-myeloma protein with different concentrations of
anti-human IgE antibody produces a concentration-dependent increase bo
th in aggregation and histamine release. The same effects were obtaine
d using platelets from atopic donors directly stimulated with anti-IgE
. The electron microscopic pattern of platelet aggregation induced by
thrombin was indistinguishable from that evoked by anti-IgE in IgE pre
treated platelets. Loratadine, a non-sedative H-1-receptor blocker, si
gnificantly abated platelet aggregation and histamine release induced
by anti-IgE in IgE pretreated platelets.